-
1
-
-
0029131231
-
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents
-
Bedi A., Barber J.P., Bedi G.C., el-Deiry W.S., Sidransky D., Vala M.S., Akhtar A.J., Hilton J., Jones R.J.: BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents. Blood, 1995; 86: 1148-1158
-
(1995)
Blood
, vol.86
, pp. 1148-1158
-
-
Bedi, A.1
Barber, J.P.2
Bedi, G.C.3
El-Deiry, W.S.4
Sidransky, D.5
Vala, M.S.6
Akhtar, A.J.7
Hilton, J.8
Jones, R.J.9
-
2
-
-
0345291171
-
Reduced folate carrier expression in acute lymphoblastic leukemia: A mechanism for ploidy but not lineage differences in methotrexate accumulation
-
Belkov V.M., Krynetski E.Y., Schuetz J.D., Yanishevski Y., Masson E., Mathew S., Raimondi S., Pui C.H., Relling M.V., Evans W.E.: Reduced folate carrier expression in acute lymphoblastic leukemia: A mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood, 1999; 93: 1643-1650
-
(1999)
Blood
, vol.93
, pp. 1643-1650
-
-
Belkov, V.M.1
Krynetski, E.Y.2
Schuetz, J.D.3
Yanishevski, Y.4
Masson, E.5
Mathew, S.6
Raimondi, S.7
Pui, C.H.8
Relling, M.V.9
Evans, W.E.10
-
3
-
-
0032793987
-
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
-
Byrd J.C., Dodge R.K., Carroll A., Baer M.R., Edwards C., Stamberg J., Qumsiyeh M., Moore J.O., Mayer R.J., Davey F., Schiffer C.A., Bloomfield C.D.: Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J. Clin. Oncol., 1999; 17: 3767-3775
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 3767-3775
-
-
Byrd, J.C.1
Dodge, R.K.2
Carroll, A.3
Baer, M.R.4
Edwards, C.5
Stamberg, J.6
Qumsiyeh, M.7
Moore, J.O.8
Mayer, R.J.9
Davey, F.10
Schiffer, C.A.11
Bloomfield, C.D.12
-
4
-
-
0035873817
-
Improved treatment results in highrisk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93
-
Creutzig U., Ritter J., Zimmermann M., Reinhardt D., Hermann J., Berthold F., Henze G., Jurgens H., Kabisch H., Havers W., Reiter A., Kluba U., Niggli F., Gadner H.: Improved treatment results in highrisk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93. J. Clin. Oncol., 2001; 19: 2705-2713
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 2705-2713
-
-
Creutzig, U.1
Ritter, J.2
Zimmermann, M.3
Reinhardt, D.4
Hermann, J.5
Berthold, F.6
Henze, G.7
Jurgens, H.8
Kabisch, H.9
Havers, W.10
Reiter, A.11
Kluba, U.12
Niggli, F.13
Gadner, H.14
-
5
-
-
0031754926
-
Mechanisms of cellular anthracycline resistance in childhood acute leukemia
-
Den Boer M.L., Pieters R., Veerman A.J.: Mechanisms of cellular anthracycline resistance in childhood acute leukemia. Leukemia, 1998; 12: 1657-1670
-
(1998)
Leukemia
, vol.12
, pp. 1657-1670
-
-
Den Boer, M.L.1
Pieters, R.2
Veerman, A.J.3
-
7
-
-
33748775148
-
-
W: Onkologia kliniczna (Red: Krzakowski M.) Warszawa: Borgis
-
Dwilewicz-Trojaczek J.: Bialaczki u doroslych. W: Onkologia kliniczna (Red: Krzakowski M.) Warszawa: Borgis, 2001; 528-555
-
(2001)
Bialaczki U Doroslych
, pp. 528-555
-
-
Dwilewicz-Trojaczek, J.1
-
8
-
-
0027172914
-
Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells
-
Evans C.A., Owen-Lynch P.J., Whetton A.D., Dive C.: Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Cancer Res., 1993; 53: 1735-1738
-
(1993)
Cancer Res.
, vol.53
, pp. 1735-1738
-
-
Evans, C.A.1
Owen-Lynch, P.J.2
Whetton, A.D.3
Dive, C.4
-
9
-
-
4944260679
-
Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia
-
Frost B.M., Forestier E., Gustafsson G., Nygren P., Hellebostad M., Jonsson O.G., Kanerva J., Schmiegelow K., Larsson R., Lonnerholm G.: Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. Blood, 2004; 104: 2452-2457
-
(2004)
Blood
, vol.104
, pp. 2452-2457
-
-
Frost, B.M.1
Forestier, E.2
Gustafsson, G.3
Nygren, P.4
Hellebostad, M.5
Jonsson, O.G.6
Kanerva, J.7
Schmiegelow, K.8
Larsson, R.9
Lonnerholm, G.10
-
10
-
-
19944426879
-
Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia
-
Frost B.M., Forestier E., Gustafsson G., Nygren P., Hellebostad M., Jonmundsson G., Kanerva J., Schmiegelow K., Larsson R., Lonnerholm G., Nordic Society for Paediatric Haematology and Oncology: Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia, 2005; 19: 165-169
-
(2005)
Leukemia
, vol.19
, pp. 165-169
-
-
Nordic Society for Paediatric Haematology and Oncology1
Frost, B.M.2
Forestier, E.3
Gustafsson, G.4
Nygren, P.5
Hellebostad, M.6
Jonmundsson, G.7
Kanerva, J.8
Schmiegelow, K.9
Larsson, R.10
Lonnerholm, G.11
-
11
-
-
0018569942
-
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
-
Goldie J.H., Coldman A.J.: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep., 1979; 63: 1727-1733
-
(1979)
Cancer Treat. Rep.
, vol.63
, pp. 1727-1733
-
-
Goldie, J.H.1
Coldman, A.J.2
-
12
-
-
0034758836
-
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
-
Grimwade D.: The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Pract. Res. Clin. Haematol., 2001; 14: 497-529
-
(2001)
Best Pract. Res. Clin. Haematol.
, vol.14
, pp. 497-529
-
-
Grimwade, D.1
-
13
-
-
0035469883
-
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
-
Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J., Wheatley K., Burnett A.K., Goldstone A.H., Medical Research Council Adult Leukemia Working Party: The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood, 2001; 98: 1312-1320
-
(2001)
Blood
, vol.98
, pp. 1312-1320
-
-
Medical Research Council Adult Leukemia Working Party1
Grimwade, D.2
Walker, H.3
Harrison, G.4
Oliver, F.5
Chatters, S.6
Harrison, C.J.7
Wheatley, K.8
Burnett, A.K.9
Goldstone, A.H.10
-
14
-
-
0032188805
-
The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties
-
Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A.: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 1998; 92: 2322-2333
-
(1998)
Blood
, vol.92
, pp. 2322-2333
-
-
Grimwade, D.1
Walker, H.2
Oliver, F.3
Wheatley, K.4
Harrison, C.5
Harrison, G.6
Rees, J.7
Hann, I.8
Stevens, R.9
Burnett, A.10
Goldstone, A.11
-
15
-
-
3543054544
-
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
-
Holleman A., Cheok M.H., Den Boer M.L., Yang W., Veerman A.J., Kazemier K.M., Pei D., Cheng C., Pui C.H., Relling M.V., Janka-Schaub G.E., Pieters R., Evans W.E.: Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N. Engl. J. Med., 2004; 351: 533-542
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 533-542
-
-
Holleman, A.1
Cheok, M.H.2
Den Boer, M.L.3
Yang, W.4
Veerman, A.J.5
Kazemier, K.M.6
Pei, D.7
Cheng, C.8
Pui, C.H.9
Relling, M.V.10
Janka-Schaub, G.E.11
Pieters, R.12
Evans, W.E.13
-
16
-
-
0344305439
-
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia
-
Holleman A., Den Boer M.L., Kazemier K.M., Janka-Schaub G.E., Pieters R.: Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood, 2003; 102: 4541-4546
-
(2003)
Blood
, vol.102
, pp. 4541-4546
-
-
Holleman, A.1
Den Boer, M.L.2
Kazemier, K.M.3
Janka-Schaub, G.E.4
Pieters, R.5
-
17
-
-
0036781785
-
Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing
-
Hongo T., Okada S., Inoue N., Yamada S., Yajima S., Watanabe C., Fujii Y., Horikoshi Y.: Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing. Int. J. Hematol., 2002; 76: 251-259
-
(2002)
Int. J. Hematol.
, vol.76
, pp. 251-259
-
-
Hongo, T.1
Okada, S.2
Inoue, N.3
Yamada, S.4
Yajima, S.5
Watanabe, C.6
Fujii, Y.7
Horikoshi, Y.8
-
18
-
-
0033249770
-
Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, Lasparaginase, and vincristine in childhood acute lymphoblastic leukemia
-
Hongo T., Yamada S., Yajima S., Watanabe C., Fujii Y., Kawasaki H., Yazaki M., Hanada R., Horikoshi Y.: Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, Lasparaginase, and vincristine in childhood acute lymphoblastic leukemia. Int. J. Hematol., 1999; 70: 268-277
-
(1999)
Int. J. Hematol.
, vol.70
, pp. 268-277
-
-
Hongo, T.1
Yamada, S.2
Yajima, S.3
Watanabe, C.4
Fujii, Y.5
Kawasaki, H.6
Yazaki, M.7
Hanada, R.8
Horikoshi, Y.9
-
19
-
-
0025097885
-
Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia
-
Kalwinsky D.K., Raimondi S.C., Schell M.J., Mirro J.Jr., Santana V.M., Behm F., Dahl G.V., Williams D.: Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J. Clin. Oncol., 1990; 8: 75-83
-
(1990)
J. Clin. Oncol.
, vol.8
, pp. 75-83
-
-
Kalwinsky, D.K.1
Raimondi, S.C.2
Schell, M.J.3
Mirro, J.4
Santana, V.M.5
Behm, F.6
Dahl, G.V.7
Williams, D.8
-
20
-
-
0028909201
-
Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study
-
Kaspers G.J., Smets L.A., Pieters R., Van Zantwijk C.H., Van Wering E.R., Veerman A.J.: Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study. Blood, 1995; 85: 751-756
-
(1995)
Blood
, vol.85
, pp. 751-756
-
-
Kaspers, G.J.1
Smets, L.A.2
Pieters, R.3
Van Zantwijk, C.H.4
Van Wering, E.R.5
Veerman, A.J.6
-
21
-
-
0030038426
-
Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome
-
Kumagai M., Manabe A., Pui C.H., Behm F.G., Raimondi S.C., Hancock M.L., Mahmoud H., Crist W.M., Campana D.: Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J. Clin. Invest., 1996; 97: 755-760
-
(1996)
J. Clin. Invest.
, vol.97
, pp. 755-760
-
-
Kumagai, M.1
Manabe, A.2
Pui, C.H.3
Behm, F.G.4
Raimondi, S.C.5
Hancock, M.L.6
Mahmoud, H.7
Crist, W.M.8
Campana, D.9
-
22
-
-
0028239707
-
Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: Prognostic implications
-
Kuss B.J., Deeley R.G., Cole S.P., Willman C.L., Kopecky K.J., Wolman S.R., Eyre H.J., Lane S.A., Nancarrow J.K., Whitmore S.A.: Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet, 1994; 343: 1531-1534
-
(1994)
Lancet
, vol.343
, pp. 1531-1534
-
-
Kuss, B.J.1
Deeley, R.G.2
Cole, S.P.3
Willman, C.L.4
Kopecky, K.J.5
Wolman, S.R.6
Eyre, H.J.7
Lane, S.A.8
Nancarrow, J.K.9
Whitmore, S.A.10
-
23
-
-
0030795080
-
Molecular cytogenetics of childhood acute myelogenous leukaemias
-
Leblanc T., Berger R.: Molecular cytogenetics of childhood acute myelogenous leukaemias. Eur. J. Haematol., 1997; 59: 1-13
-
(1997)
Eur. J. Haematol.
, vol.59
, pp. 1-13
-
-
Leblanc, T.1
Berger, R.2
-
24
-
-
4644238010
-
Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes
-
Lindvall C., Furge K., Bjorkholm M., Guo X., Haab B., Blennow E., Nordenskjold M., Teh B.T.: Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes. Haematologica, 2004; 89: 1072-1081
-
(2004)
Haematologica
, vol.89
, pp. 1072-1081
-
-
Lindvall, C.1
Furge, K.2
Bjorkholm, M.3
Guo, X.4
Haab, B.5
Blennow, E.6
Nordenskjold, M.7
Teh, B.T.8
-
25
-
-
0032530350
-
Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German multicenter trials GMALL 03/87 and 04/89
-
Ludwig W.D., Rieder H., Bartram C.R., Heinze B., Schwartz S., Gassmann W., Loffler H., Hossfeld D., Heil G., Handt S., Heyll A., Diedrich H., Fischer K., Weiss A., Volkers B., Aydemir U., Fonatsch C., Gokbuget N., Thiel E., Hoelzer D.: Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood, 1998; 92: 1898-1909
-
(1998)
Blood
, vol.92
, pp. 1898-1909
-
-
Ludwig, W.D.1
Rieder, H.2
Bartram, C.R.3
Heinze, B.4
Schwartz, S.5
Gassmann, W.6
Loffler, H.7
Hossfeld, D.8
Heil, G.9
Handt, S.10
Heyll, A.11
Diedrich, H.12
Fischer, K.13
Weiss, A.14
Volkers, B.15
Aydemir, U.16
Fonatsch, C.17
Gokbuget, N.18
Thiel, E.19
Hoelzer, D.20
more..
-
26
-
-
0030825408
-
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups
-
Mandelli F., Diverio D., Avvisati G., Luciano A., Barbui T., Bernasconi C., Broccia G., Cerri R., Falda M., Fioritoni G., Leoni F., Liso V., Petti M.C., Rodeghiero F., Saglio G., Vegna M.L., Visani G., Jehn U., Willemze R., Muus P., Pelicci P.G., Biondi A., Lo Coco F.: Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood, 1997; 90: 1014-1021
-
(1997)
Blood
, vol.90
, pp. 1014-1021
-
-
Mandelli, F.1
Diverio, D.2
Avvisati, G.3
Luciano, A.4
Barbui, T.5
Bernasconi, C.6
Broccia, G.7
Cerri, R.8
Falda, M.9
Fioritoni, G.10
Leoni, F.11
Liso, V.12
Petti, M.C.13
Rodeghiero, F.14
Saglio, G.15
Vegna, M.L.16
Visani, G.17
Jehn, U.18
Willemze, R.19
Muus, P.20
Pelicci, P.G.21
Biondi, A.22
Lo Coco, F.23
more..
-
27
-
-
0034906769
-
Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children
-
Mann G., Reinhardt D., Ritter J., Hermann J., Schmitt K., Gadner H., Creutzig U.: Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann. Hematol., 2001; 80: 417-422
-
(2001)
Ann. Hematol.
, vol.80
, pp. 417-422
-
-
Mann, G.1
Reinhardt, D.2
Ritter, J.3
Hermann, J.4
Schmitt, K.5
Gadner, H.6
Creutzig, U.7
-
28
-
-
84946562474
-
-
W: Treatment of acute leukemias. New directions for clinical research. (Red: Pui C.H.) Totowa: Humana Press
-
Marie J.P., Legrand O.: Drug resistance in acute leukemias. W: Treatment of acute leukemias. New directions for clinical research. (Red: Pui C.H.) Totowa: Humana Press, 2003: 497-505
-
(2003)
Drug Resistance in Acute Leukemias
, pp. 497-505
-
-
Marie, J.P.1
Legrand, O.2
-
29
-
-
0342424184
-
Chromosomal rearrangements in childhood acute myeloid leukemia and myelodysplastic syndromes
-
Martinez-Climent J.A., Garcia-Conde J.: Chromosomal rearrangements in childhood acute myeloid leukemia and myelodysplastic syndromes. J. Pediatr. Hematol. Oncol., 1999; 21: 91-102
-
(1999)
J. Pediatr. Hematol. Oncol.
, vol.21
, pp. 91-102
-
-
Martinez-Climent, J.A.1
Garcia-Conde, J.2
-
30
-
-
0028918255
-
Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo
-
Martinez-Climent J.A., Lane N.J., Rubin C.M., Morgan E., Johnstone H.S., Mick R., Murphy S.B., Vardiman J.W., Larson R.A., Le Beau M.M.: Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia, 1995; 9: 95-101
-
(1995)
Leukemia
, vol.9
, pp. 95-101
-
-
Martinez-Climent, J.A.1
Lane, N.J.2
Rubin, C.M.3
Morgan, E.4
Johnstone, H.S.5
Mick, R.6
Murphy, S.B.7
Vardiman, J.W.8
Larson, R.A.9
Le Beau, M.M.10
-
31
-
-
0029962417
-
Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia
-
Matherly L.H., Taub J.W.: Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia. Leuk. Lymphoma, 1996; 21: 359-368
-
(1996)
Leuk. Lymphoma
, vol.21
, pp. 359-368
-
-
Matherly, L.H.1
Taub, J.W.2
-
32
-
-
0029154446
-
Corticosteroid resistance is increased in lymphoblasts from adults compared with children: Preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia
-
Maung Z.T., Reid M.M., Matheson E., Taylor P.R., Proctor S.J., Hall A.G.: Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia. Br. J. Haematol., 1995; 91: 93-100
-
(1995)
Br. J. Haematol.
, vol.91
, pp. 93-100
-
-
Maung, Z.T.1
Reid, M.M.2
Matheson, E.3
Taylor, P.R.4
Proctor, S.J.5
Hall, A.G.6
-
34
-
-
1842289846
-
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: A cancer and leukemia group B study
-
Mrozek K., Heinonen K., Lawrence D., Carroll A.J., Koduru P.R., Rao K.W., Strout M.P., Hutchison R.E., Moore J.O., Mayer R.J., Schiffer C.A., Bloomfield C.D.: Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: A cancer and leukemia group B study. Blood, 1997; 90: 4532-4538
-
(1997)
Blood
, vol.90
, pp. 4532-4538
-
-
Mrozek, K.1
Heinonen, K.2
Lawrence, D.3
Carroll, A.J.4
Koduru, P.R.5
Rao, K.W.6
Strout, M.P.7
Hutchison, R.E.8
Moore, J.O.9
Mayer, R.J.10
Schiffer, C.A.11
Bloomfield, C.D.12
-
35
-
-
20244380336
-
Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage
-
Palle J., Frost B.M., Forestier E., Gustafsson G., Nygren P., Hellebostad M., Jonsson O.G., Kanerva J., Schmiegelow K., Larsson R., Lonnerholm G.: Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. Br. J. Haematol., 2005; 129: 189-198
-
(2005)
Br. J. Haematol.
, vol.129
, pp. 189-198
-
-
Palle, J.1
Frost, B.M.2
Forestier, E.3
Gustafsson, G.4
Nygren, P.5
Hellebostad, M.6
Jonsson, O.G.7
Kanerva, J.8
Schmiegelow, K.9
Larsson, R.10
Lonnerholm, G.11
-
36
-
-
0031717981
-
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants
-
Pieters R., Den Boer M.L., Durian M., Janka G., Schmiegelow K., Kaspers G.J., van Wering E.R., Veerman A.J.: Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants. Leukemia, 1998; 12: 1344-1348
-
(1998)
Leukemia
, vol.12
, pp. 1344-1348
-
-
Pieters, R.1
Den Boer, M.L.2
Durian, M.3
Janka, G.4
Schmiegelow, K.5
Kaspers, G.J.6
Van Wering, E.R.7
Veerman, A.J.8
-
37
-
-
0030889437
-
Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia
-
Pieters R., Klumper E., Kaspers G.J., Veerman A.J.: Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Crit. Rev. Oncol. Hematol., 1997; 25: 11-26
-
(1997)
Crit. Rev. Oncol. Hematol.
, vol.25
, pp. 11-26
-
-
Pieters, R.1
Klumper, E.2
Kaspers, G.J.3
Veerman, A.J.4
-
38
-
-
31444450907
-
Clinical relevance of multidrug resistance proteins in patients with de novo acute myeloid leukemia
-
Podolak-Dawidziak M., Dus D., Kielbiñski M., Paprocka M., Wojdat E., Lenart K., Szyda A., Haus O., Kuliszkiewicz-Janus M., Prajs I., Kuliczkowski K.: Clinical relevance of multidrug resistance proteins in patients with de novo acute myeloid leukemia. Adv. Clin. Exp. Med., 2005; 14: 1151-1160
-
(2005)
Adv. Clin. Exp. Med.
, vol.14
, pp. 1151-1160
-
-
Podolak-Dawidziak, M.1
Dus, D.2
Kielbiñski, M.3
Paprocka, M.4
Wojdat, E.5
Lenart, K.6
Szyda, A.7
Haus, O.8
Kuliszkiewicz-Janus, M.9
Prajs, I.10
Kuliczkowski, K.11
-
39
-
-
0032572912
-
Acute lymphoblastic leukemia
-
Pui C.H., Evans W.E.: Acute lymphoblastic leukemia. N. Engl. J. Med., 1998; 339: 605-615
-
(1998)
N. Engl. J. Med.
, vol.339
, pp. 605-615
-
-
Pui, C.H.1
Evans, W.E.2
-
40
-
-
0033485565
-
Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821
-
Raimondi S.C., Chang M.N., Ravindranath Y., Behm F.G., Gresik M.V., Steuber C.P., Weinstein H.J., Carroll A.J.: Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood, 1999; 94: 3707-3716
-
(1999)
Blood
, vol.94
, pp. 3707-3716
-
-
Raimondi, S.C.1
Chang, M.N.2
Ravindranath, Y.3
Behm, F.G.4
Gresik, M.V.5
Steuber, C.P.6
Weinstein, H.J.7
Carroll, A.J.8
-
41
-
-
0029940952
-
Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia
-
Raimondi S.C., Pui C.H., Hancock M.L., Behm F.G., Filatov L., Rivera G.K.: Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia, 1996; 10: 213-224
-
(1996)
Leukemia
, vol.10
, pp. 213-224
-
-
Raimondi, S.C.1
Pui, C.H.2
Hancock, M.L.3
Behm, F.G.4
Filatov, L.5
Rivera, G.K.6
-
42
-
-
1542608515
-
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype
-
Ramakers-van Woerden N.L., Beverloo H.B., Veerman A.J., Camitta B.M., Loonen A.H., Van Wering E.R., Slater R.M., Harbott J., Den Boer M.L., Ludwig W.D., Haas O.A., Janka-Schaub G.E., Pieters R.: In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia, 2004; 18: 521-529
-
(2004)
Leukemia
, vol.18
, pp. 521-529
-
-
Ramakers-Van Woerden, N.L.1
Beverloo, H.B.2
Veerman, A.J.3
Camitta, B.M.4
Loonen, A.H.5
Van Wering, E.R.6
Slater, R.M.7
Harbott, J.8
Den Boer, M.L.9
Ludwig, W.D.10
Haas, O.A.11
Janka-Schaub, G.E.12
Pieters, R.13
-
43
-
-
0036256957
-
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups
-
Ramakers-van Woerden N.L., Pieters R., Hoelzer D., Slater R.M., Den Boer M.L., Loonen A.H., Harbott J., Janka-Schaub G.E., Ludwig W.D., Ossenkoppele G.J., van Wering E.R., Veerman A.J., Dutch and German Leukemia Study Groups: In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups. Med. Pediatr. Oncol., 2002; 38: 379-386
-
(2002)
Med. Pediatr. Oncol.
, vol.38
, pp. 379-386
-
-
Dutch and German Leukemia Study Groups1
Ramakers-Van Woerden, N.L.2
Pieters, R.3
Hoelzer, D.4
Slater, R.M.5
Den Boer, M.L.6
Loonen, A.H.7
Harbott, J.8
Janka-Schaub, G.E.9
Ludwig, W.D.10
Ossenkoppele, G.J.11
Van Wering, E.R.12
Veerman, A.J.13
-
44
-
-
0034254770
-
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia
-
Ramakers-van Woerden N.L., Pieters R., Loonen A.H., Hubeek I., van Drunen E., Beverloo H.B., Slater R.M., Harbott J., Seyfarth J., van Wering E.R., Hahlen K., Schmiegelow K., Janka-Schaub G.E., Veerman A.J.: TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood, 2000; 96: 1094-1099
-
(2000)
Blood
, vol.96
, pp. 1094-1099
-
-
Ramakers-Van Woerden, N.L.1
Pieters, R.2
Loonen, A.H.3
Hubeek, I.4
Van Drunen, E.5
Beverloo, H.B.6
Slater, R.M.7
Harbott, J.8
Seyfarth, J.9
Van Wering, E.R.10
Hahlen, K.11
Schmiegelow, K.12
Janka-Schaub, G.E.13
Veerman, A.J.14
-
45
-
-
18444409012
-
Infants with acute lymphoblastic leukemia: No evidence for high methotrexate resistance
-
Ramakers-van Woerden N.L., Pieters R., Rots M.G., van Zantwijk C.H., Noordhuis P., Beverloo H.B., Peters G.J., van Wering E.R., Camitta B.M., Pui C.H., Relling M.V., Evans W.E., Veerman A.J.: Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance. Leukemia, 2002; 16: 949-951
-
(2002)
Leukemia
, vol.16
, pp. 949-951
-
-
Ramakers-Van Woerden, N.L.1
Pieters, R.2
Rots, M.G.3
Van Zantwijk, C.H.4
Noordhuis, P.5
Beverloo, H.B.6
Peters, G.J.7
Van Wering, E.R.8
Camitta, B.M.9
Pui, C.H.10
Relling, M.V.11
Evans, W.E.12
Veerman, A.J.13
-
46
-
-
0032860321
-
Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party
-
Riley L.C., Hann I.M., Wheatley K., Stevens R.F.: Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party. Br. J. Haematol., 1999; 106: 436-444
-
(1999)
Br. J. Haematol.
, vol.106
, pp. 436-444
-
-
Riley, L.C.1
Hann, I.M.2
Wheatley, K.3
Stevens, R.F.4
-
47
-
-
0036659931
-
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
-
Schnittger S., Schoch C., Dugas M., Kern W., Staib P., Wuchter C., Loffler H., Sauerland C.M., Serve H., Buchner T., Haferlach T., Hiddemann W.: Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 2002; 100: 59-66
-
(2002)
Blood
, vol.100
, pp. 59-66
-
-
Schnittger, S.1
Schoch, C.2
Dugas, M.3
Kern, W.4
Staib, P.5
Wuchter, C.6
Loffler, H.7
Sauerland, C.M.8
Serve, H.9
Buchner, T.10
Haferlach, T.11
Hiddemann, W.12
-
48
-
-
0032532289
-
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome
-
Schrappe M., Arico M., Harbott J., Biondi A., Zimmermann M., Conter V., Reiter A., Valsecchi M.G., Gadner H., Basso G., Bartram C.R., Lampert F., Riehm H., Masera G.: Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood, 1998; 92: 2730-2741
-
(1998)
Blood
, vol.92
, pp. 2730-2741
-
-
Schrappe, M.1
Arico, M.2
Harbott, J.3
Biondi, A.4
Zimmermann, M.5
Conter, V.6
Reiter, A.7
Valsecchi, M.G.8
Gadner, H.9
Basso, G.10
Bartram, C.R.11
Lampert, F.12
Riehm, H.13
Masera, G.14
-
49
-
-
0034210549
-
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALLBFM 90. German-Austrian-Swiss ALL-BFM Study Group
-
Schrappe M., Reiter A., Ludwig W.D., Harbott J., Zimmermann M., Hiddemann W., Niemeyer C., Henze G., Feldges A., Zintl F., Kornhuber B., Ritter J., Welte K., Gadner H., Riehm H.: Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALLBFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood, 2000; 95: 3310-3322
-
(2000)
Blood
, vol.95
, pp. 3310-3322
-
-
Schrappe, M.1
Reiter, A.2
Ludwig, W.D.3
Harbott, J.4
Zimmermann, M.5
Hiddemann, W.6
Niemeyer, C.7
Henze, G.8
Feldges, A.9
Zintl, F.10
Kornhuber, B.11
Ritter, J.12
Welte, K.13
Gadner, H.14
Riehm, H.15
-
51
-
-
13344282725
-
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
-
Shurtleff S.A., Buijs A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., Chan G.F., Pui C.H., Grosveld G., Downing J.R.: TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 1995; 9: 1985-1989
-
(1995)
Leukemia
, vol.9
, pp. 1985-1989
-
-
Shurtleff, S.A.1
Buijs, A.2
Behm, F.G.3
Rubnitz, J.E.4
Raimondi, S.C.5
Hancock, M.L.6
Chan, G.F.7
Pui, C.H.8
Grosveld, G.9
Downing, J.R.10
-
52
-
-
0031454013
-
Intensified therapy for infants with acute lymphoblastic leukemia: Results from the Dana-Farber Cancer Institute Consortium
-
Silverman L.B., McLean T.W., Gelber R.D., Donnelly M.J., Gilliland D.G., Tarbell N.J., Sallan S.E.: Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer, 1997; 80: 2285-2295
-
(1997)
Cancer
, vol.80
, pp. 2285-2295
-
-
Silverman, L.B.1
McLean, T.W.2
Gelber, R.D.3
Donnelly, M.J.4
Gilliland, D.G.5
Tarbell, N.J.6
Sallan, S.E.7
-
53
-
-
0031958821
-
Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: Results of the United Kingdom Medical Research Council's 10th AML trial
-
Stevens R.F., Hann I.M., Wheatley K., Gray R.G.: Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br. J. Haematol., 1998; 101: 130-140
-
(1998)
MRC Childhood Leukaemia Working Party. Br. J. Haematol.
, vol.101
, pp. 130-140
-
-
Stevens, R.F.1
Hann, I.M.2
Wheatley, K.3
Gray, R.G.4
-
54
-
-
0036284672
-
Differential chemosensitivity in a child with congenital relapsing acute lymphoblastic leukemia
-
Styczynski J., Koltan A., Haus O., Wysocki M.: Differential chemosensitivity in a child with congenital relapsing acute lymphoblastic leukemia. Pediatr. Hematol. Oncol., 2002; 19: 355-360
-
(2002)
Pediatr. Hematol. Oncol.
, vol.19
, pp. 355-360
-
-
Styczynski, J.1
Koltan, A.2
Haus, O.3
Wysocki, M.4
-
55
-
-
0033760960
-
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia
-
Styczynski J., Pieters R., Huismans D.R., Schuurhuis G.J., Wysocki M., Veerman A.J.: In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Br. J. Haematol., 2000; 110: 813-818
-
(2000)
Br. J. Haematol.
, vol.110
, pp. 813-818
-
-
Styczynski, J.1
Pieters, R.2
Huismans, D.R.3
Schuurhuis, G.J.4
Wysocki, M.5
Veerman, A.J.6
-
56
-
-
17944398583
-
Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia
-
Styczynski J., Wysocki M.: Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia. Haematologia, 2002; 32: 313-325
-
(2002)
Haematologia
, vol.32
, pp. 313-325
-
-
Styczynski, J.1
Wysocki, M.2
-
57
-
-
0036192430
-
In vitro drug resistance profiles of adult acute lymphoblastic leukemia: Possible explanation for difference in outcome to similar therapeutic regimens
-
Styczynski J., Wysocki M.: In vitro drug resistance profiles of adult acute lymphoblastic leukemia: possible explanation for difference in outcome to similar therapeutic regimens. Leuk. Lymphoma, 2002; 43: 301-307
-
(2002)
Leuk. Lymphoma
, vol.43
, pp. 301-307
-
-
Styczynski, J.1
Wysocki, M.2
-
58
-
-
4243422007
-
Mechanisms of drug resistance in acute leukemias: Therapeutic problem
-
Styczynski J., Wysocki M.: Mechanisms of drug resistance in acute leukemias: therapeutic problem. Adv. Clin. Exp. Med., 2000; 9: 153-161
-
(2000)
Adv. Clin. Exp. Med.
, vol.9
, pp. 153-161
-
-
Styczynski, J.1
Wysocki, M.2
-
59
-
-
0028063423
-
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia
-
Synold T.W., Relling M.V., Boyett J.M., Rivera G.K., Sandlund J.T., Mahmoud H., Crist W.M., Pui C.H., Evans W.E.: Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J. Clin. Invest., 1994; 94: 1996-2001
-
(1994)
J. Clin. Invest.
, vol.94
, pp. 1996-2001
-
-
Synold, T.W.1
Relling, M.V.2
Boyett, J.M.3
Rivera, G.K.4
Sandlund, J.T.5
Mahmoud, H.6
Crist, W.M.7
Pui, C.H.8
Evans, W.E.9
-
61
-
-
23644455476
-
Drug therapy for acute myeloid leukemia
-
Tallman M.S., Gilliland D.G., Rowe J.M.: Drug therapy for acute myeloid leukemia. Blood, 2005; 106: 1154-1163
-
(2005)
Blood
, vol.106
, pp. 1154-1163
-
-
Tallman, M.S.1
Gilliland, D.G.2
Rowe, J.M.3
-
62
-
-
10044264623
-
Down syndrome, drug metabolism and chromosome 21
-
Taub J.W., Ge Y.: Down syndrome, drug metabolism and chromosome 21. Pediatr. Blood Cancer, 2005; 44: 33-39
-
(2005)
Pediatr. Blood Cancer
, vol.44
, pp. 33-39
-
-
Taub, J.W.1
Ge, Y.2
-
63
-
-
0033566994
-
Expression of chromosome 21-localized genes in acute myeloid leukemia: Differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin
-
Taub J.W., Huang X., Matherly L.H., Stout M.L., Buck S.A., Massey G.V., Becton D.L., Chang M.N., Weinstein H.J., Ravindranath Y.: Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood, 1999; 94: 1393-1400
-
(1999)
Blood
, vol.94
, pp. 1393-1400
-
-
Taub, J.W.1
Huang, X.2
Matherly, L.H.3
Stout, M.L.4
Buck, S.A.5
Massey, G.V.6
Becton, D.L.7
Chang, M.N.8
Weinstein, H.J.9
Ravindranath, Y.10
-
64
-
-
0037097716
-
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis
-
Thiede C., Steudel C., Mohr B., Schaich M., Schakel U., Platzbecker U., Wermke M., Bornhauser M., Ritter M., Neubauer A., Ehninger G., Illmer T.: Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 2002; 99: 4326-4335
-
(2002)
Blood
, vol.99
, pp. 4326-4335
-
-
Thiede, C.1
Steudel, C.2
Mohr, B.3
Schaich, M.4
Schakel, U.5
Platzbecker, U.6
Wermke, M.7
Bornhauser, M.8
Ritter, M.9
Neubauer, A.10
Ehninger, G.11
Illmer, T.12
-
65
-
-
0031897537
-
Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro
-
Tosi P., Visani G., Ottaviani E., Testoni N., Pellacani A., Tura S.: Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro. Eur. J. Haematol., 1998; 60: 161-165
-
(1998)
Eur. J. Haematol.
, vol.60
, pp. 161-165
-
-
Tosi, P.1
Visani, G.2
Ottaviani, E.3
Testoni, N.4
Pellacani, A.5
Tura, S.6
-
66
-
-
0026518781
-
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study
-
Trueworthy R., Shuster J., Look T., Crist W., Borowitz M., Carroll A., Frankel L., Harris M., Wagner H., Haggard M.: Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J. Clin. Oncol., 1992; 10: 606-613
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 606-613
-
-
Trueworthy, R.1
Shuster, J.2
Look, T.3
Crist, W.4
Borowitz, M.5
Carroll, A.6
Frankel, L.7
Harris, M.8
Wagner, H.9
Haggard, M.10
-
67
-
-
0023520883
-
Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients
-
Uckun F.M., Kersey J.H., Gajl-Peczalska K.J., Heerema N.A., Provisor A.J., Haag D., Gilchrist G., Song C.W., Arthur D.C., Roloff J.: Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients. J. Clin. Invest., 1987; 80: 639-646
-
(1987)
J. Clin. Invest.
, vol.80
, pp. 639-646
-
-
Uckun, F.M.1
Kersey, J.H.2
Gajl-Peczalska, K.J.3
Heerema, N.A.4
Provisor, A.J.5
Haag, D.6
Gilchrist, G.7
Song, C.W.8
Arthur, D.C.9
Roloff, J.10
-
68
-
-
0032449896
-
Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study
-
Whitehead V.M., Vuchich M.J., Cooley L.D., Lauer S.J., Mahoney D.H., Shuster J.J., Payment C., Koch P.A., Akabutu J.J., Bowen T., Kamen B.A., Ravindranath Y., Emami A., Look A.T., Beardsley G.P., Pullen D.J., Camitta B.: Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Leuk. Lymphoma, 1998; 31: 507-519
-
(1998)
Leuk. Lymphoma
, vol.31
, pp. 507-519
-
-
Whitehead, V.M.1
Vuchich, M.J.2
Cooley, L.D.3
Lauer, S.J.4
Mahoney, D.H.5
Shuster, J.J.6
Payment, C.7
Koch, P.A.8
Akabutu, J.J.9
Bowen, T.10
Kamen, B.A.11
Ravindranath, Y.12
Emami, A.13
Look, A.T.14
Beardsley, G.P.15
Pullen, D.J.16
Camitta, B.17
-
69
-
-
0035165636
-
A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission
-
Woods W.G., Neudorf S., Gold S., Sanders J., Buckley J.D., Barnard D.R., Dusenbery K., DeSwarte J., Arthur D.C., Lange B.J., Kobrinsky N.L., Children's Cancer Group: A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood, 2001; 197: 56-62
-
(2001)
Blood
, vol.197
, pp. 56-62
-
-
Woods, W.G.1
Neudorf, S.2
Gold, S.3
Sanders, J.4
Buckley, J.D.5
Barnard, D.R.6
Dusenbery, K.7
DeSwarte, J.8
Arthur, D.C.9
Lange, B.J.10
Kobrinsky, N.L.11
Cancer Group, C.12
-
71
-
-
0036221447
-
Increased incidence of spontaneous apoptosis in the bone marrow of hyperdiploid childhood acute lymphoblastic leukemia
-
Zhang Y., Lu J., Van den Berghe J., Lee S.H.: Increased incidence of spontaneous apoptosis in the bone marrow of hyperdiploid childhood acute lymphoblastic leukemia. Exp. Hematol., 2002; 30: 333-339
-
(2002)
Exp. Hematol.
, vol.30
, pp. 333-339
-
-
Zhang, Y.1
Lu, J.2
Van Den Berghe, J.3
Lee, S.H.4
-
72
-
-
0036838528
-
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities
-
Zwaan C.M., Kaspers G.J., Pieters R., Hahlen K., Huismans D.R., Zimmermann M., Harbott J., Slater R.M., Creutzig U., Veerman A.J.: Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities. Blood, 2002; 100: 3352-3360
-
(2002)
Blood
, vol.100
, pp. 3352-3360
-
-
Zwaan, C.M.1
Kaspers, G.J.2
Pieters, R.3
Hahlen, K.4
Huismans, D.R.5
Zimmermann, M.6
Harbott, J.7
Slater, R.M.8
Creutzig, U.9
Veerman, A.J.10
-
73
-
-
0036098159
-
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome
-
Zwaan C.M., Kaspers G.J., Pieters R., Hahlen K., Janka-Schaub G.E., van Zantwijk C.H., Huismans D.R., de Vries E., Rots M.G., Peters G.J., Jansen G., Creutzig U., Veerman A.J.: Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood, 2002; 99: 245-251
-
(2002)
Blood
, vol.99
, pp. 245-251
-
-
Zwaan, C.M.1
Kaspers, G.J.2
Pieters, R.3
Hahlen, K.4
Janka-Schaub, G.E.5
Van Zantwijk, C.H.6
Huismans, D.R.7
De Vries, E.8
Rots, M.G.9
Peters, G.J.10
Jansen, G.11
Creutzig, U.12
Veerman, A.J.13
-
74
-
-
0141482006
-
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: Prognostic significance and relation to cellular drug resistance
-
Zwaan C.M., Meshinchi S., Radich J.P., Veerman A.J., Huismans D.R., Munske L., Podleschny M., Hahlen K., Pieters R., Zimmermann M., Reinhardt D., Harbott J., Creutzig U., Kaspers G.J., Griesinger F.: FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood, 2003; 102: 2387-2394
-
(2003)
Blood
, vol.102
, pp. 2387-2394
-
-
Zwaan, C.M.1
Meshinchi, S.2
Radich, J.P.3
Veerman, A.J.4
Huismans, D.R.5
Munske, L.6
Podleschny, M.7
Hahlen, K.8
Pieters, R.9
Zimmermann, M.10
Reinhardt, D.11
Harbott, J.12
Creutzig, U.13
Kaspers, G.J.14
Griesinger, F.15
|